Ampliphi Biosciences Corp (APHB) Short Interest Update
Ampliphi Biosciences Corp (NYSE:APHB) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 974,681 shares, a drop of 2.6% from the August 15th total of 1,001,044 shares. Approximately 11.4% of the company’s shares are sold short. Based on an average daily trading volume, of 104,382 shares, the short-interest ratio is currently 9.3 days.
Ampliphi Biosciences Corp (NYSE APHB) opened at 1.02 on Tuesday. Ampliphi Biosciences Corp has a 52 week low of $0.67 and a 52 week high of $17.50. The company’s market cap is $8.92 million. The company’s 50-day moving average is $0.85 and its 200-day moving average is $1.08.
Ampliphi Biosciences Corp Company Profile
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Stock Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related stocks with our FREE daily email newsletter.